Literature DB >> 27060861

Risk assessment of drug-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a disproportionality analysis using the French Pharmacovigilance Database.

M S Agier1, N Boivin1, A Maruani2,3,4, B Giraudeau3,5, A Gouraud6, F Haramburu7, M J Jean Pastor8, L Machet2,3,4, A P Jonville-Bera9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27060861     DOI： 10.1111/bjd.14649

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  4 in total

Review 1.  Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and the Rheumatologist.

Authors:  Marwan H Adwan
Journal:  Curr Rheumatol Rep       Date:  2017-01       Impact factor: 4.686

2.  Drug Reaction with Eosinophilia and Systemic Symptoms: Retrospective Analysis of 104 Cases over One Decade.

Authors:  Li Wang; Xue-Ling Mei
Journal:  Chin Med J (Engl)       Date:  2017-04-20       Impact factor: 2.628

3.  Severe Cutaneous Adverse Drug Reactions Associated with Allopurinol: An Analysis of Spontaneous Reporting System in Southern Italy.

Authors:  Cristina Scavone; Cristina Di Mauro; Rosanna Ruggiero; Francesca Futura Bernardi; Ugo Trama; Maria Luisa Aiezza; Concetta Rafaniello; Annalisa Capuano
Journal:  Drugs Real World Outcomes       Date:  2020-03

4.  DRESS syndrome in response to Denosumab: First documented case report.

Authors:  Mariam Al-Attar; Maria De Santis; Marco Massarotti
Journal:  Bone Rep       Date:  2019-12-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.